Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report issued to clients and investors on Wednesday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Performance

NYSE ENZ opened at $0.50 on Wednesday. The business has a 50 day simple moving average of $0.68 and a two-hundred day simple moving average of $0.96. Enzo Biochem has a 1-year low of $0.41 and a 1-year high of $1.40.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Institutional Investors Weigh In On Enzo Biochem

Institutional investors have recently modified their holdings of the stock. Virtu Financial LLC bought a new stake in shares of Enzo Biochem in the 4th quarter valued at approximately $35,000. BBR Partners LLC bought a new stake in shares of Enzo Biochem in the 3rd quarter valued at approximately $112,000. Lepercq De Neuflize Asset Management LLC bought a new stake in shares of Enzo Biochem in the 4th quarter valued at approximately $88,000. Wittenberg Investment Management Inc. lifted its stake in shares of Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after purchasing an additional 70,400 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares during the last quarter. 36.90% of the stock is owned by institutional investors.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.